BioWorld

April 22, 2002

View Archived Issues

MedImmune Enters Licensing Deals For Two Cancer Products

MedImmune Inc. agreed to spend an undisclosed amount of money expanding its cancer program through the licensure of two early stage technologies. (BioWorld Today) Read More

Telik, Sanwa Kagaku Extend Collaboration For Third Time

Read More

Calcium Prescribed To Ward Off Osteoporosis In Postmenopause Netted Good’ Cholesterol Bonus

Read More

Coastal City’s Misnamed Crabs Supporting Device, Drug Safety

Read More

Other News To Note

Read More

Appointments And Advancements

Read More

U.S. Patent Disclosures

Read More